OUTCOMES OF OPEN MAJOR HEPATECTOMY FOR LIVER MALIGNANCIES AT THE VIET DUC UNIVERSITY HOSPITAL
Main Article Content
Abstract
Objective: To describe clinical and paraclinical characteristics and evaluate early outcomes of open major hepatectomy for liver cancer.
Methods: A retrospective descriptive study was conducted on 80 patients who underwent open major hepatectomy at the Department of Oncology and Radiotherapy, Viet Duc University Hospital from January 2016 to December 2022.
Results: The mean age was 52.9 ± 12.5 years, and 73.7% were male. Hepatocellular carcinoma was the most common histological type (67.5%). Tumors ≥ 5 cm accounted for 86.3% of cases. The combined Ton That Tung - Lortat-Jacob technique was used in 92.5% of patients. Mean operative time was 233.4 ± 64.7 minutes, and intraoperative blood transfusion was required in 27.5%. R0 resection was achieved in 91.3% of cases. Postoperative complications included pleural effusion (42.5%) and liver failure (3.8%). No bile leakage, reoperation, or postoperative mortality was recorded. Mean postoperative hospital stay was 11.4 ± 3.9 days. Intra- and postoperative blood transfusion was significantly associated with postoperative complications (p < 0.05).
Conclusion: Open major hepatectomy for liver cancer demonstrates favorable early outcomes and high safety
Article Details
Keywords
Major hepatectomy, liver cancer, postoperative complications, early outcomes.
References
[2] Nguyễn Cường Thịnh, Lê Văn Thành và cộng sự. Kết quả cắt gan kết hợp phương pháp Tôn Thất Tùng - Lortat-Jacob điều trị ung thư biểu mô tế bào gan. Tạp chí Y Dược học lâm sàng 108, 2011, 6 (số đặc biệt): 278-283.
[3] Ninh Việt Khải. Nghiên cứu ứng dụng cặp kiểm soát chọn lọc cuống gan trong cắt gan theo phương pháp Tôn Thất Tùng. Luận án tiến sĩ y học, Học viện Quân y, 2018.
[4] Figueras J, Lopez-Ben S, Lladó L, Rafecas A, Torras J, Ramos E et al. Hilar dissection versus the “Glissonean” approach and stapling of the pedicle for major hepatectomies. Ann Surg, 2003, 238 (1): 111-9. doi: 10.1097/01.SLA.0000074981.02000.69.
[5] Reig M, Forner A, Rimola J, Ferrer-Fàbrega J, Burrel M, Garcia-Criado Á et al. BCLC strategy for prognosis prediction and treatment recommendation: the 2022 update. Journal of Hepatology, 2022, 76 (3): 681-93. doi: 10.1016/j.jhep.2021.11.018.
[6] European Association for the Study of the Liver. EASL clinical practice guidelines on the management of hepatocellular carcinoma. Journal of Hepatology, 2025, 82 (2): 315-374. doi: 10.1016/j.jhep.2024.08.028.
[7] Nguyễn Hoàng. Nghiên cứu đặc điểm lâm sàng, cận lâm sàng và kết quả phẫu thuật cắt gan do ung thư tế bào gan sau nút động mạch gan. Luận án tiến sĩ y học, Trường Đại học Y Hà Nội, 2017.
[8] Jarnagin W.R, Gonen M, Fong Y, DeMatteo R.P, Ben-Porat L, Little S et al. Improvement in perioperative outcome after hepatic resection. Ann Surg, 2002, 236 (4): 397-407. https://pmc.ncbi.nlm.nih.gov/articles/PMC1422593/
[9] Trịnh Quốc Đạt. Nghiên cứu ứng dụng kỹ thuật kiểm soát chọn lọc cuống Glisson trong cắt gan điều trị ung thư tế bào gan. Luận văn tiến sĩ y học, Trường Đại học Y Hà Nội, 2019.
[10] Makuuchi M, Takayasu K, Takuma T, Yamazaki S, Hasegawa H, Nishiura S et al. Preoperative transcatheter embolization of the portal venous branch for patients receiving extended lobectomy due to the bile duct carcinoma. The Journal of the Japanese Practical Surgeon Society, 1984, 45 (12): 1558-64. doi: 10.3919/ringe1963.45.1558